Riskpilot← Back to searchSign inGet full accessMOTUSKLINIKKEN AS
ASActiveOrg 918898662Kirkebakken 17, 3184 BorreWholesale of pharmaceutical and medical goods · NACE 4646Est. 20170 employees
Revenue 2024
NOK 7K
-84% vs 2023
EBITDA margin
77.9%
-82% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -17K
-2710% vs 2023
| Revenue | NOK 7K | -84% |
| EBITDA | NOK 5K | -82% |
| Net profit | NOK -17K | -2710% |
| Total assets | NOK 16K | -81% |
| Equity | NOK 16K | -51% |
| Employees | 0 | — |
Legal name
MOTUSKLINIKKEN AS
Org number
918898662
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2. mai 2017
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Kjøp og salg, samt utleie av maskiner og utstyr mot helseforetak, inkludert alle former for tjenester knyttet til å utøve dette, herunder eierskap i andre foretak
Address
Kirkebakken 17, 3184 Borre
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 85 | 35 | 44 | 44 | 7 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 28 | 33 | 42 | 30 | 5 |
| Depreciation & amort. | −30 | −30 | −30 | −30 | −22 |
| EBIT | −2 | 3 | 12 | 0 | −17 |
| Net financials | −0 | 0 | 0 | 0 | −0 |
| Profit before tax | −3 | 3 | 12 | 0 | −17 |
| Tax | −0 | −0 | −0 | 1 | −0 |
| Net profit | −3 | 3 | 12 | −1 | −17 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 189 | 158 | 117 | 85 | 16 |
| Equity | 19 | 22 | 34 | 33 | 16 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 170 | 135 | 83 | 52 | 0 |
| Total debt | 170 | 135 | 83 | 52 | 0 |
EBITDA margin
77.9%
This company
15.8%
Market median
+393% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-103.7%
This company
18.4%
Market median
-664% vs market
20202024
Net profit margin
-243.6%
This company
8.1%
Market median
-3107% vs market
20202024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TR Chief Executive Officer | Chief Executive Officer | 2017 |
| Former (1) | ||
TR Chief Executive Officer | Chief Executive Officer | 2017 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Motto As
MOTUSKLINIKKEN AS Board members of MOTUSKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tobias Ruud Elvestad | Chief Executive Officer | 0 companies |
| Tobias Ruud Askim Elvestad | Chief Executive Officer | 0 companies |
| Geir Elvestad | Chairman | 0 companies |